References
- Andrews C, Abraham A, Grogan CM, et al. Despite resources from the ACA, most states do little to help addiction treatment programs implement health care reform. Health Aff. 2015;34(5):828–835
- Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription opioid use, misuse, and use disorders in US adults: 2015 National Survey on Drug Use and Health. Ann Intern Med. 2017;167:293–301.
- Sullivan MD, Edlund MJ, Fan MY, DeVries A, Braden J, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000–2005 in commercial and Medicaid insurance plans: the TROUP Study. Pain. 2008;138(2):440–449.
- Harris SK, Herr-Zaya K, Weinstein Z, et al. Results of a statewide survey of adolescent substance use screening rates and practices in primary care. Subst Abus. 2012;33(4):321–326.
- Beaton A, Shubkin CD, Chapman S. Addressing substance misuse in adolescents: a review of the literature on the screening, brief intervention, and referral to treatment model. Curr Opin Pediatr. 2016,28:258–265
- National Committee for Quality Assurance. http://www.ncqa.org/report-cards/health-plans/state-of-health-care-quality/2017-table-of-contents/alcohol-treatment. Accessed March 26, 2018.
- The Henry J. Kaiser Family Foundation. The Kaiser Family Foundation state health facts: trends in Medicaid income eligibility limits. https://www.kff.org/data-collection/trends-in-medicaid-income-eligibility-limits/. Accessed August 16, 2018.
- National Committee for Quality Assurance. HEDIS 2014: healthcare effectiveness data and information set. Technical specifications for health plans. Vol 2. Washington, DC: National Committee for Quality Assurance; 2013.
- Rural-Urban Commuting Area Codes. US Department of Agriculture, Economic Research Service. https://www.ers.usda.gov/data-products/rural-urban-commuting-area-codes.aspx. Accessed March 26, 2018.
- Kronick R, Gilmer T, Dreyfus T, Lee L. Improving health-based payment for Medicaid beneficiaries: CDPS (chronic illness and disability payment system). Health Care Financ Rev. 2000;21(3):29.
- Hadland SE, Wharam JF, Schuster MA, Zhang F, Samet JH, Larochelle MR. Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001–2014. JAMA Pediatr. 2017;171(8):747–755.
- Yarborough BJ, Chi FW, Green CA, et al. Patient and system characteristics associated with performance on the HEDIS measures of alcohol and other drug treatment initiation and engagement. J Addict Med. 2018;12:278–286.
- Stein BD, Kogan JN, Sorbero M. Substance abuse detoxification and residential treatment among Medicaid-enrolled adults: rates and duration of subsequent treatment. Drug Alcohol Depend. 2009;104:100–106.
- McCaul ME, Svikis DS, Moore RD: Predictors of outpatient treatment retention: patient versus substance use characteristics. Drug Alcohol Depend. 2001;62:9–17.
- Levy S, Mountain-Ray S, Reynolds J, Mendes SJ, Bromberg J. A novel approach to treating adolescents with opioid use disorder in pediatric primary care. Subst Abuse. 2018;29:1–9.
- Ozechowski TJ, Becker SJ, Hogue A. SBIRT-A: adapting SBIRT to maximize development fit for adolescents in primary care. J Subs Abuse Treat. 2016;62:28–37
- Winstanley EL, Steinwachs, Stitzer ML, Fishman MJ. Adolescent substance abuse and mental health: problem co-occurrence and access to services. J Child Adolesc Subst Abuse. 2012;21(4):310–322.
- Cummings JR, Wen H, Ko M, Druff BG. Race/ethnicity and geographic access to Medicaid substance use disorder treatment facilities in the United States. JAMA Psychiatry. 2014;71(2):190–196
- Yeterian JD, Greene MC, Bergman BG, Kelly JF. Does mandated treatment benefit youth? A prospective investigation of adolescent justice system involvement, treatment motivation, and substance use outcomes. Alcohol Treat Q. 2013;31(4):431–434